Announcements

4 November 2026

Safeguarding patients from adulterated complementary health products: Responsibilities of TCM practitioners

2 November 2026

Report suspected side effects from medicines to your healthcare professional

1 November 2026

Recall of Tetrabenazine 25mg 112’s Sun-Italy

Retail-level recall of one batch of Tetrabenazine 25mg 112’s Sun-Italy, containing tetrabenazine, due to presence of black spots on the tablets.

29 October 2026

HSA Charges 38-Year-Old Male for Alleged Trafficking of Etomidate Vaporiser Pods

26 October 2026

Mean applicant screening response time

HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or non-acceptance/withdrawal of the application (excluding applicant’s response time) is 50 working days (WD).

21 October 2026

Haze Advisory for Blood Donors

21 October 2026

Recall of DANTRIUM 20 mg Powder for Solution for Injection

Retail-level recall of one batch of DANTRIUM 20 mg Powder for Solution for Injection, containing dantrolene, due to presence of visible foreign particulate matter in the vials.

12 October 2026

Health Sciences Authority Strengthens Local and Global Partnerships to Accelerate Healthcare Innovations

12 October 2026

Keynote Address by Adj Prof (Dr) Raymond Chua, Chief Executive Officer, Health Sciences Authority, at the Inaugural Health Regulatory Conference 2026

12 October 2026

Recall of Clonotril (Clonazepam) 0.5 Tablet 0.5 mg

Retail-level recall of several batches of Clonotril 0.5 Tablet 0.5 mg due to out-of-specification results in stability study